Body And Mind Stock Performance
| BMMJ Stock | USD 0.01 0.00 0.00% |
The firm shows a Beta (market volatility) of 0.37, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Body's returns are expected to increase less than the market. However, during the bear market, the loss of holding Body is expected to be smaller as well. At this point, Body and Mind has a negative expected return of -0.77%. Please make sure to confirm Body's variance, as well as the relationship between the value at risk and rate of daily change , to decide if Body and Mind performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Body and Mind has generated negative risk-adjusted returns adding no value to investors with long positions. Even with fragile performance in the last few months, the Stock's primary indicators remain relatively steady which may send shares a bit higher in December 2024. The new chaos may also be a sign of medium-term up-swing for the company stakeholders. ...more
| Begin Period Cash Flow | 7.4 M |
Body |
Body Relative Risk vs. Return Landscape
If you would invest 3.00 in Body and Mind on September 1, 2024 and sell it today you would lose (2.00) from holding Body and Mind or give up 66.67% of portfolio value over 90 days. Body and Mind is currently does not generate positive expected returns and assumes 13.3969% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than Body, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Body Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Body's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Body and Mind, and traders can use it to determine the average amount a Body's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0573
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | BMMJ |
Estimated Market Risk
| 13.4 actual daily | 96 96% of assets are less volatile |
Expected Return
| -0.77 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.06 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Body is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Body by adding Body to a well-diversified portfolio.
Body Fundamentals Growth
Body Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Body, and Body fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Body Pink Sheet performance.
| Return On Equity | -1.47 | |||
| Return On Asset | -0.0932 | |||
| Profit Margin | (0.97) % | |||
| Operating Margin | (0.18) % | |||
| Current Valuation | 18.77 M | |||
| Shares Outstanding | 146.64 M | |||
| Price To Book | 0.32 X | |||
| Price To Sales | 0.27 X | |||
| Revenue | 31.64 M | |||
| EBITDA | (21.51 M) | |||
| Cash And Equivalents | 3.71 M | |||
| Cash Per Share | 0.03 X | |||
| Total Debt | 7.39 M | |||
| Debt To Equity | 0.44 % | |||
| Book Value Per Share | 0.06 X | |||
| Cash Flow From Operations | (3.44 M) | |||
| Earnings Per Share | (0.04) X | |||
| Total Asset | 31.03 M | |||
About Body Performance
By evaluating Body's fundamental ratios, stakeholders can gain valuable insights into Body's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Body has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Body has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Body and Mind Inc. cultivates, processes, distributes, and retails medical and recreational cannabis in Nevada, California, Arkansas, Ohio, and Michigan in the United States. Body and Mind Inc. was incorporated in 1998 and is headquartered in Vancouver, Canada. Body Mind is traded on OTC Exchange in the United States.Things to note about Body and Mind performance evaluation
Checking the ongoing alerts about Body for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Body and Mind help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Body and Mind generated a negative expected return over the last 90 days | |
| Body and Mind has high historical volatility and very poor performance | |
| Body and Mind has some characteristics of a very speculative penny stock | |
| Body and Mind has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 31.64 M. Net Loss for the year was (28.68 M) with profit before overhead, payroll, taxes, and interest of 6.32 M. | |
| Body and Mind currently holds about 3.71 M in cash with (3.44 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.03, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
- Analyzing Body's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Body's stock is overvalued or undervalued compared to its peers.
- Examining Body's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Body's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Body's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Body's pink sheet. These opinions can provide insight into Body's potential for growth and whether the stock is currently undervalued or overvalued.
Other Information on Investing in Body Pink Sheet
Body financial ratios help investors to determine whether Body Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Body with respect to the benefits of owning Body security.